1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Precision cut tumor slices as an ex vivo model to assess myeloid biology and function in the tumor microenvironment
- Master (Two yrs)
-
Mark
Activation of Antigen Presenting Cells Following Stimulation with a CD40-CEACAM5 Bispecific Antibody, in an ex vivo Esophagogastric Adenocarcinoma Model
- Master (Two yrs)
- 2024
-
Mark
Assay optimization for spatial omics analysis of oropharyngeal cancer tissue
- Master (Two yrs)
-
Mark
Optimization of a multiplexed immunofluorescent panel for identification of myeloid cell subpopulations and their impact on survival of head and neck squamous cell carcinoma
- Master (Two yrs)
- 2023
-
Mark
Mass spectrometry-based proteomic characterization of peripheral immune cells
- Master (Two yrs)
-
Mark
The bispecific CD40xEpCAM antibody increase activation in human antigen presenting cell subsets and induce CD8+ T cell proliferation to a greater extent compared to monospecific antibodies
- Univ. Diploma
-
Mark
Development and testing of autologous in vitro models for their ability to mimic the immune system’s response toward immunotherapies
- Master (Two yrs)
-
Mark
Study of the immunological response from an OMV-based vaccine using ELISA
- Master (Two yrs)
-
Mark
Development of in vitro models that test and predict immune-mediated adverse toxicities
- Master (Two yrs)
- 2022
-
Mark
In vitro assay development and optimization for the prediction of immune-related adverse events following immunotherapy
- Master (Two yrs)